57.王先生55歲，因non-Hodgkin lymphoma已接受二次癌症化學..-阿摩線上測驗

上一題

57.王先生55歲，因non-Hodgkin lymphoma已接受二次癌症化學治療，回診抱怨口腔與食道吞嚥時刺痛，檢查發現口腔內潰瘍處有白色斑塊；目前用藥包括：prednisolone、pantoprazole及oral hypoglycemics。依序回答下列三題。下列何者不是口腔內潰瘍處產生白色斑塊的危險因子？
(A)prednisolone
(B)癌症化學治療
(C)pantoprazole
(D)55歲

專技 - 藥物治療學- 109 年 - 109-2 專技高考_藥師（二）：藥物治療學#89128

答案：登入後觀看
難度： 適中

討論
私人筆記( 0 )

最佳解!
	江光庭高二上 (2021/01/19) pantoprazole抑制胃酸會改.....看完整詳解檢舉

查看全部8則討論

	6F 傑德國三下 (2021/04/28) Acid suppressing therapy as a risk factor for Candida esophagitis H W Daniell 1PMID: 25833302 DOI: 10.1111/dote.12354 Abstract Studies were reviewed from PubMed for risk factors for the development, recurrence, prevention and therapy of Candida esophagitis, and for mechanisms induced by acid-suppressing therapy potentially influencing these factors. Documented observations included greatly increased Candida populations in the mouth, esophagus, stomach, and upper small intestine induced by acid-suppressing therapy. Among patients without HIV disease, PPI consumers more frequently had develop... 查看完整內容 Acid suppressing therapy as a risk factor for Candida esophagitis H W Daniell 1 PMID: 25833302 DOI: 10.1111/dote.12354 Abstract Studies were reviewed from PubMed for risk factors for the development, recurrence, prevention and therapy of Candida esophagitis, and for mechanisms induced by acid-suppressing therapy potentially influencing these factors. Documented observations included greatly increased Candida populations in the mouth, esophagus, stomach, and upper small intestine induced by acid-suppressing therapy. Among patients without HIV disease, PPI consumers more frequently had developed Candida esophagitis than did non-consumers and had also developed its recurrences more frequently. Similar phenomena associated with H2 -blocker use were less intense, and the possibility of similar phenomena in patients with HIV disease apparently had not yet been examined in spite of their high frequency of this disorder. PPI-induced elimination of the gastric acid barrier is a major mechanism leading to oro-pharyngeal and esophageal candida colonization, while PPI-induced impairment of absorption of most orally administered antifungal agents may limit the prophylactic and therapeutic success of these agents. These observations suggest potential value in limiting PPI use in populations of patients with Candida infections including esophagitis, as well as in patients at risk for their development, and also suggest that post-PPI rebound acid hypersecretion may provide additional anti-Candida benefit. Studies designed to develop the risk-benefit ratios of PPI use in these patients deserve investigation with high priority appropriate for studies in patients with HIV disease. 檢舉
	7F Irene 高二上 (2021/04/28) (A)口腔念珠菌感染(類固醇) (☆)... (內容隱藏中) 查看隱藏文字
	8F 唉牙牙牙高三上 (2021/07/16) 47.李小姐確診胃幽門桿菌感染，醫師處方三合一療法。藥師的用藥指導，下列何者最不適當？ (A)須遵照醫囑服用抗生素，以降低治療失敗及抗藥性的發生 (B)PPI的服用時間建議在午餐飯後30～60分鐘及睡前，每天2次 (C)三合一療法常見的輕微副作用為噁心、腹痛及腹瀉 (D)可能會發生鵝口瘡或是陰道念珠菌感染編輯私有筆記及自訂標籤專技 - 調劑學與臨床藥學- 109 年 - 109-1 專技高考_藥師(二)：調劑學與臨床藥學#82766 答案：B 難度：簡單統計： A(6),B(2170),C(36),D(964),E(0) #2180091 檢舉

你可以購買他人私人筆記。

57.王先生55歲，因non-Hodgkin lymphoma已接受二次癌症化學..-阿摩線上測驗

專技 - 藥物治療學題庫下載題庫

Acid suppressing therapy as a risk factor for Candida esophagitis